The Pennant Group 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- For the 3 months ended September 30th, 2026, The Pennant Group reported revenue of $302.3 million, adjusted EBITDA of $24.7 million, adjusted EBITDA prior to NCI of $26.1 million, GAAP diluted earnings per share of $0.26, and adjusted diluted earnings per share of $0.35.
- Compared with the prior year quarter, revenue increased 32%, adjusted EBITDA increased 42.4%, adjusted EBITDA prior to NCI increased 44%, and adjusted earnings per share increased 16.7%.
- Home Health and Hospice segment revenue was $239.8 million, up 38.2%, and segment-adjusted EBITDA was $38.1 million, up 42%, compared with the prior year quarter.
- Senior living segment revenue was $62.4 million, up 12.6%, and adjusted EBITDA was $5.7 million, up 3%, compared with the prior year quarter.
- The company reported $103 million outstanding on its line of credit, $18.4 million cash on hand at quarter end, 1.95 times net debt to adjusted EBITDA, and cash flows provided from operations of $25.1 million in Q3 and $43.5 million year-to-date.
- Higher-than-anticipated employee benefits costs across the portfolio pressured margins and modestly affected earnings; management said the impact was about 50 bps of revenue in Q3.
- Home health total admissions grew 39.4% and Medicare admissions grew 38%; same-store total admissions increased 8%, Medicare admissions increased 12%, and revenue per episode increased 3.5%, each compared with the prior year quarter.
- Hospice total admissions increased 31.8%, total average daily census increased 34.6%, and revenue per day improved 2.1%; same-store admissions increased 3.1%, ADC increased 13%, and revenue per day improved 3.7%, each compared with the prior year quarter.
- Same-store margin increased 80 basis points compared with the prior year quarter; the potentially preventable hospitalization rate was 9.9%, compared with an industry average of 10.8%, and the CMS-reported hospice quality composite score was 98.3%, compared with an industry average of 96.6%.
- On August 1st, the company acquired the real estate and operations of River Center Assisted Living, a 63-unit community in Tucson, Arizona; in September, it acquired the real estate associated with Main Place Senior Living in Orange, California.
- Integration of the 54 locations purchased from UnitedHealth and Amedisys in the Southeast was nearly complete; the EMR transition was completed on October 31st.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Thank you for standing by. Welcome to The Pennant Group Third Quarter 2026 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Kirk Cheney, Executive Vice President. Please go ahead. Thank you, Dee Dee.
Welcome, everyone, and thank you for joining us today. Here with me today, I have Brent Guerisoli, our CEO, John Gochnour, our President and COO, Lynette Walbom, our CFO, and Andy Rider, our Senior Living President. Before we begin, I have a few housekeeping matters. We filed our earnings press release and 10-Q yesterday. This announcement is available on the Investor Relations section of our website at www.pennantgroup.com. A replay of this call will also be available on our website until 5:00 P.M. Mountain Time on November 5, 2027. We want to remind anyone who may be listening to a replay of this call that all statements made are as of today, November 5, 2026, and these statements will not be updated after today's call.
Also, any forward-looking statements made today are based on management's current expectations, assumptions, and beliefs about our business and the environment in which we operate. These statements are subject to risks and uncertainties that could cause our actual results to materially differ from those expressed or implied on today's call. Listeners should not place undue reliance on forward-looking statements and are encouraged to review our SEC filings for a more complete discussion of factors that could impact our results. Except as required by federal securities laws, Pennant and its affiliates do not undertake to publicly update or revise any forward-looking statements where changes arise from new information, future events, changing circumstances, or any other reason. In addition, The Pennant Group, Inc. is a holding company with no direct operating assets, employees, or revenues.
Certain of our independent subsidiaries, collectively referred to as the service center, contract to provide administrative services to the other operating subsidiaries. The words Pennant, company, we, our, and us refer to The Pennant Group, Inc. and its consolidated subsidiaries. All of our operating subsidiaries and the service center are operated by separate independent companies that have their own management, employees, and assets. References herein to the consolidated company and its assets and activities, as well as the use of the terms we, us, our, and similar terms, do not imply that The Pennant Group, Inc. has direct operating assets, employees, or revenue, or that any of the subsidiaries are operated by The Pennant Group. Also, we supplement our GAAP reporting with non-GAAP metrics.
When viewed together with our GAAP results, we believe that these measures can provide a more complete understanding of our business, but they should not be relied upon to the exclusion of GAAP reports. A GAAP to non-GAAP reconciliation is available in yesterday's press release and is available in our 10-K. With that, we will turn the call over to Brent Guerisoli, our CEO.
Brent? Thanks, Kirk. Welcome, everyone, to our third quarter 2026 earnings call.
We are pleased to report another quarter of strong performance across Pennant. In Q3, we reported revenue of $302.3 million, an increase of 32%, Adjusted EBITDA of $24.7 million, an increase of 42.4%, Adjusted EBITDA prior to NCI of $26.1 million, an increase of 44%, and adjusted earnings per share of $0.35, an increase of 16.7%, each over the prior year quarter. Pennant continues to grow and perform at a remarkable pace. This quarter represents another important step forward in a multi-year track record of exceptional growth, consistent execution, and progress toward our long-term objectives. The strength of our performance is evident throughout our operations. On a year-over-year basis, we are now serving nearly 40% more home health patients, 35% more hospice patients, and 10% more senior living residents than we were just one year ago.
This is significant growth, and importantly, it reflects the effectiveness of our operating model and the continued execution of our local leaders and teams. We have always approached building Pennant with a long-term perspective. Our focus is not simply on delivering results in the short term, but on building an organization capable of generating exceptional growth and performance over many years. From that perspective, we see tremendous positive momentum across both of our core businesses. Our home health and hospice segment continues to perform at a high level, delivering strong year-over-year growth. Our senior living segment likewise delivered solid results, even as our teams worked through the demands of integrating several new communities. While our underlying operating performance remains strong and in line with our expectations, we experienced higher-than-anticipated employee benefits costs during the quarter, including our newly acquired operations.
These costs created additional margin pressure and modestly impacted our earnings for the quarter. We are taking steps to more predictably manage these costs going forward and have incorporated our current expectations for elevated benefits expenses into our fourth quarter projections. While additional volatility in these costs remain a potential variable, we continue to believe we are positioned to achieve our full-year guidance. We remain confident in the fundamental strength of our business, our strategy, and the significant opportunities ahead of us. On the regulatory front, the Home Health Final Rule was released yesterday and includes a 2.1% net increase in the home health payment rate, or 1.5% as applied to our claims based on the proposed rule. After several years of negative rate updates, a small increase is a step in the right direction, but it is insufficient.
To preserve access to home health services, particularly in rural areas, home health reimbursement must account for the impacts of high inflation and must appropriately compensate high-quality providers. We will continue to work with our industry partners to advance positive home health policies, and we are encouraged to see the introduction of bills in the House and the Senate that call upon those bodies to redress the persistent underfunding of home health. The Home Health Final Rule also includes several program integrity measures, which CMS intends to use to target fraudulent and illegitimate providers. We support CMS's efforts to root out fraud, but we believe several of these measures are unnecessarily broad and will impose burdens on legitimate providers. That said, we are prepared and equipped to adapt to the changes.
We continue to drive progress on the five key initiatives that have been our focus for multiple years: leadership development, clinical excellence, margin, growth, and employee experience. Over the last several years, we have invested heavily in developing leaders, strengthening our clusters, expanding our geographic footprint, and building the infrastructure necessary to support a much larger organization. On the leadership front, we have added more than 100 CEOs in training this year and continue to deploy robust C-level training across key leader roles. These investments are increasingly visible in our results. We have more talented leaders operating in more markets, a significantly broader portfolio of operations, and more opportunities to deploy the Pennant model than at any point in our history. We believe the foundation we are building, combined with the momentum we are seeing throughout the organization, positions Pennant exceptionally well for continued growth and long-term success.
With that, I'll turn the call over to John Gochnour to provide more detail on our third quarter operational results.
Thank you, Brent, and good morning, everyone. As Brent highlighted, our Q3 results show robust year-over-year improvement across our operating segments. Our Home Health and Hospice segment delivered excellent results. Segment revenue of $239.8 million increased $66.2 million, or 38.2%. Segment Adjusted EBITDA of $38.1 million increased $11.3 million, or 42%. And segment Adjusted EBITDA prior to NCI of $39.5 million increased $11.9 million, or 43%, each over the prior year quarter. This improvement was driven by strong performance of mature operations and the effective transition of newly acquired operations. Of particular note is our strong same-store performance during a period of exceptional growth. Over the last two years, we have added 75 locations to our Home Health and Hospice segment. This growth has led to significant investments in leadership, infrastructure, and service center support, enabling us to transition larger and larger acquisitions more effectively.
It has also demonstrated our ability to elevate leaders internally. As we have described before, our transition process is not led by a traditional corporate development team. Instead, our local operations teams and service center resources directly support these transitions. Our results, and especially our same-store performance, reflect the dynamic flywheel that this approach creates, as local CEOs and CCOs elevate others within their teams so they can spend time supporting transitions. In many cases, these newly elevated leaders have driven improved clinical, financial, and growth results in our same-store operations, even as our CEO and CCO group have helped effectively integrate these new agencies. As a result of these efforts across the segment, total home health admissions grew 39.4%, and Medicare admissions grew 38%, offsetting a 2.2% decline in revenue per episode due to lower rates in our new Southeast locations.
Our same-store locations on total admissions increased 8%, Medicare admissions increased 12%, and revenue per episode increased 1.6%, each over the prior year quarter, as our operators drove accelerated growth and effectively offset the Medicare rate cut. We also saw compelling hospice growth, with total admissions increasing 31.8%, total average daily census increasing 34.6%, and revenue per day improving 2.1%, each over the prior year quarter. Same-store growth was equally strong, with same-store admissions up 3.1%, ADC increasing 13%, and revenue per day improving 3.7%, each over the prior year quarter. Our local leaders continue to manage the business effectively, as despite the significant increase in benefits costs that Brent described earlier, we saw same-store margin increase 80 basis points as compared to the prior year quarter.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
11 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
